Results: 1-7 |
Results: 7

Authors: Godley, PA Taylor, M
Citation: Pa. Godley et M. Taylor, Renal cell carcinoma, CURR OPIN O, 13(3), 2001, pp. 199-203

Authors: Kornblith, AB Herndon, JE Zuckerman, E Godley, PA Savarese, D Vogelzang, NJ Holland, JC
Citation: Ab. Kornblith et al., The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study, ANN ONCOL, 12(5), 2001, pp. 633-641

Authors: Godley, PA Rathore, SS Kshirsagar, AV Amamoo, MA Schell, MJ Freeman, J Harris, RP
Citation: Pa. Godley et al., Retrospective classification of prostate-specific antigen tests: Differentiating screening from diagnostic clinical encounters, J CLIN EPID, 54(9), 2001, pp. 884-888

Authors: Savarese, DM Halabi, S Hars, V Akerley, WL Taplin, ME Godley, PA Hussain, A Small, EJ Vogelzang, NJ
Citation: Dm. Savarese et al., Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780, J CL ONCOL, 19(9), 2001, pp. 2509-2516

Authors: Godley, PA Ataga, KI
Citation: Pa. Godley et Ki. Ataga, Renal cell carcinoma, CURR OPIN O, 12(3), 2000, pp. 260-264

Authors: Godley, PA Schell, MJ
Citation: Pa. Godley et Mj. Schell, Adjusted odds ratios under nondifferential misclassification: Application to prostate cancer, J CLIN EPID, 52(2), 1999, pp. 129-136

Authors: Godley, PA
Citation: Pa. Godley, Prostate cancer screening: Promise and peril - A review, CANCER DET, 23(4), 1999, pp. 316-324
Risultati: 1-7 |